22Nov/13

Investors Alert: Amgen, Inc. (NASDAQ:AMGN), Galena Biopharma Inc (NASDAQ … – Market News Call

Investors Alert: Amgen, Inc. (NASDAQ:AMGN), Galena Biopharma Inc (NASDAQ
Market News Call
18 announced that the company’s Phase 3 study (Study 116) evaluating idelalisib in combination with rituximab in previously-treated chronic lymphocytic leukemia (CLL) patients who were not fit for chemotherapy was accepted for presentation during a 

and more »